Dicumarol inhibits PDK1 and targets multiple malignant behaviors of ovarian cancer cells.
about
A small compound spindlactone A sensitizes human endometrial cancer cells to TRAIL-induced apoptosis via the inhibition of NAD(P)H dehydrogenase quinone 1.Chemoresistance in ovarian cancer: exploiting cancer stem cell metabolism.SPARCL1 suppresses the proliferation and migration of human ovarian cancer cells via the MEK/ERK signaling
P2860
Dicumarol inhibits PDK1 and targets multiple malignant behaviors of ovarian cancer cells.
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Dicumarol inhibits PDK1 and targets multiple malignant behaviors of ovarian cancer cells.
@ast
Dicumarol inhibits PDK1 and targets multiple malignant behaviors of ovarian cancer cells.
@en
type
label
Dicumarol inhibits PDK1 and targets multiple malignant behaviors of ovarian cancer cells.
@ast
Dicumarol inhibits PDK1 and targets multiple malignant behaviors of ovarian cancer cells.
@en
prefLabel
Dicumarol inhibits PDK1 and targets multiple malignant behaviors of ovarian cancer cells.
@ast
Dicumarol inhibits PDK1 and targets multiple malignant behaviors of ovarian cancer cells.
@en
P2093
P2860
P1433
P1476
Dicumarol inhibits PDK1 and targets multiple malignant behaviors of ovarian cancer cells
@en
P2093
Liankun Sun
Shanshan Yu
Wenjia Zhang
Xiaoli Zhou
Yong Zhang
P2860
P304
P356
10.1371/JOURNAL.PONE.0179672
P407
P50
P577
2017-06-15T00:00:00Z